mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects

mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects

To identify the most efficient methods of immunological protection against SARS-CoV-2, including the currently most widespread variants of concern (VOCs)—B.1.1.7, B.1.351 and P.1—a simultaneous side-by-side-comparison of available vaccination regimes is required. In this observational cohort study,...

সম্পূর্ণ বিবরণ

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক:	Dorit Fabricius, Carolin Ludwig, Judith Scholz, Immanuel Rode, Chrysanthi Tsamadou, Eva-Maria Jacobsen, Martina Winkelmann, Aline Grempels, Ramin Lotfi, Aleš Janda, Sixten Körper, Guido Adler, Klaus-Michael Debatin, Hubert Schrezenmeier, Bernd Jahrsdörfer
বিন্যাস:	প্রবন্ধ
ভাষা:	English
প্রকাশিত:	MDPI AG 2021-08-01
মালা:	Vaccines
বিষয়গুলি:	heterologous vaccination regimes using mRNA vaccines may allow enhanced protection against SARS-CoV-2, including current VOCs RNA vaccines may facilitate rapid (re-) qualification of convalescent plasma donors with high titers of broadly neutralizing antibodies
অনলাইন ব্যবহার করুন:	https://www.mdpi.com/2076-393X/9/8/918

অনুরূপ উপাদানগুলি

BNT162b2 Vaccination Elicits Strong Serological Immune Responses Against SARS-CoV-2 Including Variants of Concern in Elderly Convalescents
অনুযায়ী: Bernd Jahrsdörfer, অন্যান্য
প্রকাশিত: (2021-09-01)

BNT162b2 Booster Vaccination Elicits Cross-Reactive Immunity Against SARS-CoV-2 Variants B.1.1.529 and B.1.617.2 in Convalescents of All Ages
অনুযায়ী: Bernd Jahrsdörfer, অন্যান্য
প্রকাশিত: (2022-06-01)

Differentially induced immunity in buccal and nasal mucosae after vaccination for SARS–CoV–2: Prospects for mass scale immunity-screening in large populations
অনুযায়ী: Chrysanthi Tsamadou, অন্যান্য
প্রকাশিত: (2022-11-01)

SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays
অনুযায়ী: Alina Seidel, অন্যান্য
প্রকাশিত: (2023-04-01)

Comparing SARS-CoV-2 neutralizing antibody levels in convalescent unvaccinated, convalescent vaccinated, and naive vaccinated subjects
অনুযায়ী: Latha Dulipsingh, অন্যান্য
প্রকাশিত: (2023-06-01)

Heterologous vaccination (ChAdOx1 and BNT162b2) induces a better immune response against the omicron variant than homologous vaccination
অনুযায়ী: Jaeeun Yoo, অন্যান্য
প্রকাশিত: (2023-10-01)

Heterologous ChAdOx1 nCoV-19/BNT162b2 Prime-Boost Vaccination Induces Strong Humoral Responses among Health Care Workers
অনুযায়ী: Louise Benning, অন্যান্য
প্রকাশিত: (2021-08-01)

Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination
অনুযায়ী: Somruedee Chatsiricharoenkul, অন্যান্য
প্রকাশিত: (2022-10-01)

Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization
অনুযায়ী: William R. Lykins, অন্যান্য
প্রকাশিত: (2024-12-01)

Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5‐included SARS‐CoV‐2 variants than homologous vaccination of mRNA vaccine
অনুযায়ী: Dandan Peng, অন্যান্য
প্রকাশিত: (2023-04-01)

Safety and Immunogenicity of a Booster Vaccination by CoronaVac or BNT162b2 in Previously Two-Dose Inactivated Virus Vaccinated Individuals with Negative Neutralizing Antibody
অনুযায়ী: Kristi Tsz-Wan Lai, অন্যান্য
প্রকাশিত: (2022-04-01)

Dynamics of Anti-S IgG Antibodies Titers after the Second Dose of COVID-19 Vaccines in the Manual and Craft Worker Population of Qatar
অনুযায়ী: Devendra Bansal, অন্যান্য
প্রকাশিত: (2023-02-01)

One-Year Post-Vaccination Longitudinal Follow-Up of Quantitative SARS-CoV-2 Anti-Spike Total Antibodies in Health Care Professionals and Evaluation of Correlation with Surrogate Neutralization Test
অনুযায়ী: Yesim Tuyji Tok, অন্যান্য
প্রকাশিত: (2023-02-01)

The predictors of high titer of anti-SARS-CoV-2 antibody of convalescent plasma donors
অনুযায়ী: Shinta Oktya Wardhani, অন্যান্য
প্রকাশিত: (2021-07-01)

Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine
অনুযায়ী: Sutima Luangdilok, অন্যান্য
প্রকাশিত: (2022-09-01)

Assessment of protective serum anti-HBsAb levels among previously HBV vaccinated medical residents and its relation to duration and doses of vaccine – single center study
অনুযায়ী: Mohamed Hashem, অন্যান্য
প্রকাশিত: (2023-11-01)

Protectivity of COVID-19 Vaccines and Its Relationship with Humoral Immune Response and Vaccination Strategy: A One-Year Cohort Study
অনুযায়ী: Ferdi Tanir, অন্যান্য
প্রকাশিত: (2022-07-01)

Efficacy, safety, and immunogenicity of SARS-CoV-2 mRNA vaccine (Omicron BA.5) LVRNA012: a randomized, double-blind, placebo-controlled phase 3 trial
অনুযায়ী: Huan Zhou, অন্যান্য
প্রকাশিত: (2024-06-01)

Antibody level dynamics until after the third dose of COVID-19 vaccination
অনুযায়ী: Nanae Asahi, অন্যান্য
প্রকাশিত: (2023-07-01)

Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao
অনুযায়ী: Hoi Man Ng, অন্যান্য
প্রকাশিত: (2023-05-01)

Corrigendum: Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao
অনুযায়ী: Hoi Man Ng, অন্যান্য
প্রকাশিত: (2024-02-01)

Is it time to define vaccines to be used for lumpy skin disease?
অনুযায়ী: Krishna Prasad Acharya, অন্যান্য
প্রকাশিত: (2024-09-01)

Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants
অনুযায়ী: Rüdiger Groß, অন্যান্য
প্রকাশিত: (2022-01-01)

Durability of immune response against omicron BA.2 and BA.4/5 and T cell responses after boosting with mRNA and adenoviral vector-based vaccines following heterologous CoronaVac/ChAdOx-1nCov-19 vaccination
অনুযায়ী: Nungruthai Suntronwong, অন্যান্য
প্রকাশিত: (2023-12-01)

Immunogenicity and safety of heterologous mRNA-1273/MVC-COV1901 vaccination versus homologous mRNA1273 vaccination: A randomized, double-blind controlled study
অনুযায়ী: Szu-Ting Huang, অন্যান্য
প্রকাশিত: (2023-11-01)

Neutralization effect of plasma from vaccinated COVID-19 convalescents on SARS-CoV-2 Omicron variants
অনুযায়ী: Yudi Xie, অন্যান্য
প্রকাশিত: (2022-09-01)

Heterologous Prime-boost COVID-19 Vaccination
অনুযায়ী: Vishal R. Tandon, অন্যান্য
প্রকাশিত: (2021-10-01)

A DNA Prime and MVA Boost Strategy Provides a Robust Immunity against Infectious Bronchitis Virus in Chickens
অনুযায়ী: Shaswath S. Chandrasekar, অন্যান্য
প্রকাশিত: (2023-01-01)

Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial
অনুযায়ী: Andreas Heinzel, অন্যান্য
প্রকাশিত: (2022-10-01)

Three-Month Follow-Up of Heterologous vs. Homologous Third SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Secondary Analysis of a Randomized Controlled Trial
অনুযায়ী: Andreas Heinzel, অন্যান্য
প্রকাশিত: (2022-07-01)

Humoral Response in Hemodialysis Patients Post-SARS-CoV-2 mRNA Vaccination: A Systematic Review of Literature
অনুযায়ী: Kin Israel Notarte, অন্যান্য
প্রকাশিত: (2023-03-01)

The Pilot Study of Immunogenicity and Adverse Events of a COVID-19 Vaccine Regimen: Priming with Inactivated Whole SARS-CoV-2 Vaccine (CoronaVac) and Boosting with the Adenoviral Vector (ChAdOx1 nCoV-19) Vaccine
অনুযায়ী: Surakameth Mahasirimongkol, অন্যান্য
প্রকাশিত: (2022-03-01)

The role of COVID‐19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical‐year medical students in Indonesia
অনুযায়ী: Rivaldo Steven Heriyanto, অন্যান্য
প্রকাশিত: (2021-12-01)

Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies
অনুযায়ী: Adrian Rice, অন্যান্য
প্রকাশিত: (2022-07-01)

Increased antibody titers but induced T cell AICD and apoptosis response in COVID-19 convalescents by inactivated vaccine booster
অনুযায়ী: Jingmin Zhao, অন্যান্য
প্রকাশিত: (2024-03-01)

Vaccination strategies, the power of the unmatched double hits
অনুযায়ী: Talal S Al-Qaisi, অন্যান্য
প্রকাশিত: (2023-10-01)

The Equal Neutralizing Effectiveness of BNT162b2, ChAdOx1 nCoV-19, and Sputnik V Vaccines in the Palestinian Population
অনুযায়ী: Alexia Damour, অন্যান্য
প্রকাশিত: (2024-05-01)

T-cell-derived TNF-α and a cluster of immunological parameters from plasma allow a separation between SARS-CoV-2 convalescent versus vaccinated elite athletes
অনুযায়ী: Jana Palmowski, অন্যান্য
প্রকাশিত: (2023-06-01)

Ethical concerns regarding heterologous COVID-19 vaccine administration
অনুযায়ী: Somsri Wiwanitkit, অন্যান্য
প্রকাশিত: (2024-12-01)

EVALUATION OF DIFFERENT ROUTES OF VACCINATION BY CLONE VACCINE ON HUMORAL ANTIBODY RESPONSE
অনুযায়ী: Moin Khodayari, অন্যান্য
প্রকাশিত: (2017-12-01)